Company Description
Ambiq Micro, Inc. develops ultra-low-power integrated circuits for power-sensitive applications.
It develops subthreshold power-optimized technology based on ultra-low-power real-time clock and microcontroller products for application in wearables, smart cards, wireless sensors, and Internet-of-Things (IoT) products.
The company’s flagship products include Apollo, a system on a chip for edge AI devices with host processors capable of software-based AI computations and Atomiq, targeting AI applications to provide AI acceleration along with new memory innovations.
The company also offers technical support services. The company offers its products through internal direct sales force and through a network of distributors and sales representatives.
Ambiq Micro, Inc. was formerly known as Cubiq Microchip, Inc. and changed its name to Ambiq Micro, Inc. in October 2012.
The company was incorporated in 2010 and is based in Austin, Texas.
| Country | United States |
| Founded | 2010 |
| IPO Date | Jul 30, 2025 |
| Industry | Semiconductors |
| Sector | Technology |
| Employees | 190 |
| CEO | Fumihide Esaka |
Contact Details
Address: 6500 River Place Boulevard, Building 7 Austin, Texas 78730 United States | |
| Phone | 512 879 2850 |
| Website | ambiq.com |
Stock Details
| Ticker Symbol | AMBQ |
| Exchange | NYSE |
| Stock Type | Common Stock |
| Fiscal Year | January - December |
| Reporting Currency | USD |
| IPO Price | $24.00 |
| CIK Code | 0001500412 |
| CUSIP Number | 023193105 |
| ISIN Number | US0231931058 |
| Employer ID | 27-1911389 |
| SIC Code | 3674 |
Key Executives
| Name | Position |
|---|---|
| Fumihide Esaka | Chief Executive Officer and Director |
| Sean Chihhsiang Chen | President and Chief Operating Officer |
| Dr. Scott McLean Hanson Ph.D. | Co-Founder, Chief Technology Officer, Secretary and Director |
| David Blaauw | Co-Founder |
| Dr. Dennis Sylvester | Co-Founder |
| Jeffrey G. Winzeler | Chief Financial Officer |
| Lisa Standley | Senior Director of Finance and Administration |
| Charlene Wan | Vice President of Corporate Marketing and Investor Relations |
| Aaron Grassian | Executive Vice President of Global Sales and Marketing |
| Dr. Kris Potrafka | Vice President of Human Resources |
Latest SEC Filings
| Date | Type | Title |
|---|---|---|
| Nov 6, 2025 | 10-Q | Quarterly Report |
| Nov 6, 2025 | 8-K | Current Report |
| Nov 3, 2025 | SCHEDULE 13G | Filing |
| Oct 3, 2025 | 8-K | Current Report |
| Sep 4, 2025 | 10-Q | Quarterly Report |
| Sep 4, 2025 | 8-K | Current Report |
| Jul 31, 2025 | S-8 | Securities to be offered to employees in employee benefit plans |
| Jul 31, 2025 | 8-K | Current Report |
| Jul 31, 2025 | 424B4 | Prospectus |
| Jul 29, 2025 | EFFECT | Notice of Effectiveness |